Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer
Not Applicable
Completed
- Conditions
- Recurrent prostate cancer after radiotherapy
- Registration Number
- JPRN-UMIN000013140
- Lead Sponsor
- Kawasaki Medical School
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Male
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
prostate cancer with hormon reflactoly
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of high-dose-rate brachytherapy in treating local recurrent prostate cancer after radiotherapy?
How does focal salvage HDR brachytherapy compare to standard salvage treatments like surgery or conventional radiotherapy for prostate cancer recurrence?
What biomarkers are associated with favorable outcomes in patients undergoing salvage HDR brachytherapy for prostate cancer?
What are the potential adverse events and management strategies for focal HDR brachytherapy in post-radiotherapy prostate cancer patients?
Are there any combination approaches involving HDR brachytherapy and systemic therapies for recurrent prostate cancer after radiotherapy?